Nyxoah SA Ordinary Shares (NYXH)
Stock · NASDAQ · Health Care
$1.13as of 10/16/2026
Price chart
Active signals
NYXH Signal Track Record
How signals performed across all stocks →What NYXH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | -3.1% | 40% | September 2, 2026 |
| Bollinger Band BreakdownActive now | 28 | -4.8% | 39% | September 22, 2026 |
| Bollinger Band Breakout | 16 | -6.9% | 44% | September 3, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -10.0% | 40% | March 26, 2025 |
| Any 20-session window (baseline) | -3.9% | 37% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NYXH
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 153
- Website
- www.nyxoah.com/
Fundamentals
- 1-day range
- $1.19$1.22
- Market cap
- $57.20M
- P/E (trailing)
- —
- P/E (forward)
- -1.45
- EPS (trailing)
- $-2.16
- Dividend yield
- —
- Beta
- 0.77
- Avg. volume
- 270.2K
Forecasts
3 analyst ratings
Nyxoah SA Ordinary Shares Competitors
Chosen by industry and closest market cap.
- NYXHNyxoah SA Ordinary Shares$1.11▼ 6.72%Market cap $57.20MP/E —$1.11$5.3
- DRIODarioHealth Corp. Common Stock$4.82▼ 6.04%Market cap $56.88MP/E —$5.03$16.5
- QTEXQTREX Quantum Ltd. Ordinary Shares$1.5▼ 5.06%Market cap $59.05MP/E —$0.283$3.85
- DXRDaxor Corporation Common Stock$10.05▼ 1.47%Market cap $61.18MP/E 10.12$8.56$14.76
- MDAISpectral AI Inc. Class A Common Stock$1.51▼ 1.95%Market cap $52.83MP/E —$1.18$2.97
- XTNTXtant Medical Holdings Inc. Common Stock$0.29▼ 3.33%Market cap $62.09MP/E 23.84$0.2702$0.95
- SNWVSANUWAVE Health Inc. Common Stock$4.96▼ 4.06%Market cap $51.59MP/E 3.11$3.92$36.42
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NYXH Nyxoah SA Ordinary Shares | $57.20M | — | $1.11 | ▼ 6.72% | $1.11$5.3 |
| DRIO DarioHealth Corp. Common Stock | $56.88M | — | $4.82 | ▼ 6.04% | $5.03$16.5 |
| QTEX QTREX Quantum Ltd. Ordinary Shares | $59.05M | — | $1.5 | ▼ 5.06% | $0.283$3.85 |
| DXR Daxor Corporation Common Stock | $61.18M | 10.12 | $10.05 | ▼ 1.47% | $8.56$14.76 |
| MDAI Spectral AI Inc. Class A Common Stock | $52.83M | — | $1.51 | ▼ 1.95% | $1.18$2.97 |
| XTNT Xtant Medical Holdings Inc. Common Stock | $62.09M | 23.84 | $0.29 | ▼ 3.33% | $0.2702$0.95 |
| SNWV SANUWAVE Health Inc. Common Stock | $51.59M | 3.11 | $4.96 | ▼ 4.06% | $3.92$36.42 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Nyxoah Submits FDA Application To Expand Genio Indication To Complete Concentric Collapse Patients; Pivotal Data Show 74.3% Median Reduction In Apnea Eventsbenzinga · 10/15/2026
- Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?Yahoo · 10/6/2026
- Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.SeekingAlpha · 10/5/2026
- Nyxoah Appoints Liam Kelly as Chief Executive OfficerYahoo · 9/28/2026
- Let's uncover which stocks are experiencing notable gaps during today's session.ChartMill · 9/28/2026
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · 9/25/2026
- CVRx names John Landry as CFOYahoo · 9/23/2026
- CVRx Appoints John Landry as Chief Financial OfficerYahoo · 9/21/2026
- Nyxoah Announces Chief Financial Officer TransitionYahoo · 9/21/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nyxoah (NYXH) appoints Liam Kelly as CEO
Nyxoah announced that Liam Kelly will serve as its new chief executive officer. The appointment follows a recent leadership transition and may shape the company's future direction. The stock is currently trading near its $1.56 support level with an RSI around 49, indicating neutral momentum.
Nyxoah (NYXH) appoints Liam Kelly as CEO. Nyxoah announced that Liam Kelly will serve as its new chief executive officer. The appointment follows a recent leadership transition and may shape the company's future direction. The stock is currently trading near its $1.56 support level with an RSI around 49, indicating neutral momentum.